Intuitive Surgical, Inc. $ISRG Shares Sold by BDF Gestion

BDF Gestion lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 55.6% during the third quarter, Holdings Channel.com reports. The firm owned 5,354 shares of the medical equipment provider’s stock after selling 6,715 shares during the quarter. BDF Gestion’s holdings in Intuitive Surgical were worth $2,177,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Bank of America Corp DE boosted its position in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after buying an additional 116,292 shares during the period. Bank of New York Mellon Corp purchased a new position in shares of Intuitive Surgical in the second quarter worth about $1,335,753,000. Amundi lifted its stake in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after acquiring an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its holdings in Intuitive Surgical by 13.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,745,008 shares of the medical equipment provider’s stock valued at $804,431,000 after acquiring an additional 211,237 shares during the period. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages have weighed in on ISRG. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Evercore set a $430.00 target price on shares of Intuitive Surgical in a report on Monday, July 6th. Oppenheimer raised shares of Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 target price on the stock in a research note on Wednesday, August 12th. Barclays upgraded shares of Intuitive Surgical to a “strong-buy” rating in a report on Wednesday, October 7th. Finally, Citigroup dropped their price target on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research report on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $498.83.

Insider Activity

In other news, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the transaction, the executive vice president owned 881 shares of the company’s stock, valued at $330,877.17. The trade was a 8.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 10,000 shares of the company’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the transaction, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

ISRG stock traded up $5.38 on Monday, reaching $432.08. 1,191,230 shares of the company traded hands, compared to its average volume of 2,403,120. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The company has a market cap of $152.65 billion, a P/E ratio of 49.53, a price-to-earnings-growth ratio of 3.22 and a beta of 1.46. The firm has a fifty day simple moving average of $391.43 and a 200-day simple moving average of $409.44.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The business had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same period in the previous year, the company posted $1.81 earnings per share. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.